NCT04585815 2026-01-09Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)PfizerPhase 1/2 Terminated34 enrolled 44 charts
NCT03898908 2025-05-21EBRAIN-MELGrupo Español Multidisciplinar de MelanomaPhase 2 Completed48 enrolled 24 charts